Evidence map›Paper›PMID 17446933›Full record

ArticleThe Journal of clinical investigation2007

Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus.

Adrian Erlebacher, Daniela Vencato, Kelly A Price, Dorothy Zhang, Laurie H Glimcher

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 221 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Reversing pregnancy-induced B cell sensitization to facilitate the induction of transplant tolerance in postpartum recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  6. Maternal Krüppel-like factor 2 (KLF2)+ CD4 T cells promote fertility and fetal tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. B Cell Responses to the Placenta and Fetus.Annual review of pathology · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Endometrial Microbiota and Immune Tolerance in Pregnancy.International journal of molecular sciences · 2023
    Review
  19. A Framework for Understanding Maternal Immunity.Immunology and allergy clinics of North America · 2023
    Review
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Adrian ErlebacherDepartment of Pathology, Experimental Pathology Program, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. adrian.erlebacher@med.nyu.edu
Daniela Vencato
Kelly A Price
Dorothy Zhang
Laurie H Glimcher
Harvard University · USNew York University · US

Funding

Mechanisms ot Maternal Immune TolerenceR01AI054370 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GLIMCHER, LAURIE HOLLIS · 2002 to 2006
$2.0M
Dendritic cell behavior at the maternal/fetal interfaceR01AI062980 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ERLEBACHER, ADRIAN · 2005 to 2009
$1.9M
NIAID NIH HHS R01 AI054370NIAID NIH HHS R01 AI 062980NIAID NIH HHS R01 AI062980NIAID NIH HHS R01 AI 54370
6 · The paper itself

Abstract

How the fetus escapes rejection by the maternal immune system remains one of the major unsolved questions in transplantation immunology. Using a system to visualize both CD4+ and CD8+ T cell responses during pregnancy in mice, we find that maternal T cells become aware of the fetal allograft exclusively through "indirect" antigen presentation, meaning that T cell engagement requires the uptake and processing of fetal/placental antigen by maternal APCs. This reliance on a relatively minor allorecognition pathway removes a major threat to fetal survival, since it avoids engaging the large number of T cells that typically drive acute transplant rejection through their ability to directly interact with foreign MHC molecules. Furthermore, CD8+ T cells that indirectly recognize fetal/placental antigen undergo clonal deletion without priming for cytotoxic effector function and cannot induce antigen-specific fetal demise even when artificially activated. Antigen presentation commenced only at mid-gestation, in association with the endovascular invasion of placental trophoblasts and the hematogenous release of placental debris. Our results suggest that limited pathways of antigen presentation, in conjunction with tandem mechanisms of immune evasion, contribute to the unique immunological status of the fetus. The pronounced degree of T cell ignorance of the fetus also has implications for the pathophysiology of immune-mediated early pregnancy loss.

Indexed as

AnimalsAntigen PresentationEgg ProteinsFemaleFetusH-2 AntigensMaleMiceMice, Inbred C57BLMice, Inbred CBAMice, KnockoutMice, TransgenicOvalbuminPeptide FragmentsPregnancyT-LymphocytesEgg ProteinsH-2 AntigensH-2Kb protein, mouseOVA-8OvalbuminPeptide Fragments

Identifiers

PMID17446933
PMCPMC1849983
OpenAlexW2145592052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.